NCT06534762View on ClinicalTrials.gov

Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study

PHASE2RecruitingINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

July 15, 2024

Primary Completion Date

July 1, 2026

Study Completion Date

July 1, 2028

Conditions
NSCLCSCLCColorectal CancerPancreas CancerTNBC - Triple-Negative Breast CancerDLBCL - Diffuse Large B Cell LymphomaSquamous Cell Carcinoma of Head and Neck
Interventions
BIOLOGICAL

Mirabegron

To explore the efficacy and safety of milaberon combined with standard treatment in advanced solid tumors

Trial Locations (1)

Unknown

RECRUITING

Zhejiang Provincial People's Hospital, Hangzhou

All Listed Sponsors
lead

Zhejiang Provincial People's Hospital

OTHER